EWTX261120C00040000
EWTX Nov 20 2026 40.00 Call
optionOPRA
EODSep 29, 2026
3.50USD-18.794%(-0.81)8Vol27OI
Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
40
Expiration
Nov 20, 2026
DTE
44d
Moneyness
OTM
Intrinsic
$0.00
EWTX 40 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $2.10 | -19.54% | 5 | 150 |
| Nov 20, 2026 | 44d | $3.50 | -18.79% | 8 | 27 |
| Dec 18, 2026 | 72d | $11.25 | +80.00% | 1 | 0 |
| Jan 15, 2027 | 100d | $8.21 | -18.71% | 100 | 39 |
| Feb 19, 2027 | 135d | $7.66 | -21.84% | 1 | 1 |
| Mar 19, 2027 | 163d | $9.35 | -16.89% | 52 | 17 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Nearby Strikes · Nov 20, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 34 C | $11.20 | +7.69% | 1 | 10 | ITM |
| 35 C | $8.30 | -25.23% | 1 | 2 | ITM |
| 36 C | $13.80 | +90.61% | 3 | 7 | ITM |
| 37 C | $6.68 | -36.20% | 1 | 113 | ITM |
| 38 C | $10.10 | +42.25% | 1 | 2 | ITM |
| 39 C | $9.39 | +55.21% | 1 | 1 | ITM |
| 40 C | $3.50 | -18.79% | 8 | 27 | OTM |
| 41 C | $8.49 | +6.13% | 1 | 2 | OTM |
| 42 C | — | — | 0 | 0 | OTM |
| 43 C | $2.75 | -64.61% | 1 | 20 | OTM |
| 44 C | $2.50 | -40.48% | 3 | 3 | OTM |
| 45 C | $2.10 | +13.51% | 1 | 80 | OTM |
| 46 C | $6.10 | +0.00% | 3 | 3 | OTM |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.